future of CRS treatment are also explored, principally with regards to probiotics.
Rhinosinusitis is a condition characterised by paranasal sinus and nasal inflammation. Symptoms include nasal blockage/obstruction/ congestion, facial pain/pressure, reduction or loss of smell, and rhinorrhoea; when these continue for over 12 weeks, the condition is classified as chronic rhinosinusitis (CRS) 1 . CRS is one of the most prevalent chronic diseases worldwide, conservatively affecting 5-6% of US adults 2 and 8.5% of Australian adults 3 . The economic burden of CRS in the US alone is approximately US$22 billion annually 4 .
Like many chronic diseases, CRS has a complex etiology, with interplay between microorganisms (bacteria, fungi and viruses), environmental disturbances (e.g. pollutants or smoking) and host factors (e.g. the immune system and underlying diseases) 5 . This article explores the role that bacteria play in CRS by examining recent research suggesting that disturbances to the sinus microbiome are involved in CRS pathophysiology.
CRS and the sinus microbiome
A microbiome is a collective term for all of the microorganisms present in an environment. Various groups of microorganisms can cause disturbances to the sinus microbiome, which can sometimes contribute to the development of CRS. For instance, an acute viral infection is the cause for many cases of sinus microbiome disturbance, but this is a short-term disturbance 1, 6 . Also, while fungi are not considered primary etiologic agents of CRS, allergies to some fungi can result in a distinct condition with similar symptoms as CRS called Allergic Fungal Rhinosinusitis
5
. However, the group of microorganisms that are the biggest players in CRS are bacteria 1, 5 .
In the past, healthy sinuses were considered sterile environments, and CRS developed when bacteria colonised these sinuses 7 . Nowadays, it is recognised that healthy sinuses house diverse microbiomes with both commensal bacteria and potentially pathogenic bacteria; the pathogens present in these healthy sinuses are present at levels too low to cause disease 6, 7 . The commensal microbes form a symbiotic relationship with the host, such as by forming a barrier against incoming external pathogens 8 . An imbalance of the sinus microbiome -termed microbiome dysbiosis -is seen in many cases of CRS, as seen by an overabundance of opportunistic pathogens and loss of key commensals 5, 6, 8, 9 . The immune system is then activated due to pathogen invasion through epithelial tight junctions and release of various immunostimulatory molecules, thus resulting in inflammation 1, 5 ( Figure 1 ).
Determining differences in the bacterial makeup of CRS or non-CRS sinuses is a relatively novel area of research. This is due to both the recent change in our understanding of CRS pathophysiology and recent advances in microbiome characterisation methods.
Traditional culture-dependent methods fail to truly represent the sinus microbiome 9, 15 , so truly accurate insights into CRS versus healthy microbiomes are from a currently limited number of molecular-based studies [9] [10] [11] [12] [15] [16] [17] [18] .
Further adding to the complexity of CRS is that there does not seem to be a 'model' CRS microbiome; that is, each CRS patient has a unique sinus microbiome composition 15, 16 . Also, even within a single CRS patient, the microbiome of each sinus is different
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However, after taking these sources of variation into consideration, there are still certain features that can distinguish between CRS and non-CRS microbiomes, as described in the next two sections. Other bacterial taxa are found to be enriched in CRS microbiomes.
Balance of bacterial taxa
Increases in Pseudomonas spp. 16 , Corynebacterium spp. 10, 16 , certain Streptococcus spp., Staphylococcus aureus, Propionibacterium acnes and Haemophilus influenzae 15, 16 have been reported in CRS. Abreu et al. 10 notably found enrichment of a novel sinopathogen Corynebacterium tuberculostearicum, typically a commensal when present on skin. Of particular importance to CRS is S. aureus. Most microbiome studies found that S. aureus was enriched in CRS patients; some even found it to be the most abundant organism in CRS sinuses 9, 11, 12, 16, 18 . Here it is important Figure 1 . Nasal mucosa microbiomes of healthy versus CRS patients. The normal nasal mucosa is colonised by a highly diverse dynamic mix of commensal microbes, and some pathogenic microbes at low abundances. Perturbations to the microbiome can lead to microbiome dysbiosis; now the sinuses have low species diversity and evenness, with loss of critical commensal species and selected enrichment of pathogens. This then leads to a loss of epithelial integrity, immune activation and sinus inflammation. The bacterial taxa presented here are a few of the commensal and pathogenic species that have been implicated in CRS disease progression. This figure is adapted from the information in the following references 5, 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] .
Hot Topic to emphasise the problem of 'correlation vs causation', as seeing increases of certain taxa in a disease state is insufficient evidence to conclude that those taxa are causing the disease. With particular regard to S. aureus, no study has been carried out to explicitly determine whether or not an increased sinus level of S. aureus will cause CRS. However, current research on S. aureus in CRS 12, 18, 20, 21 indicates that S. aureus increases the severity of CRS, and is at the very least involved in CRS development.
Bacterial load
Bacterial load is the total number of bacteria in a microbiome 8 .
There is currently disagreement in the literature on the correlation between CRS and bacterial load. This issue of emerging resistance against the most common treatment for CRS has encouraged several researchers to investigate alternative treatment options. One approach that has been recently garnering interest is the use of probiotics to restore a healthy microbiome in CRS patients.
Probiotics in CRS
A probiotic is defined as '...a live microorganism that, when administered in adequate amounts, confers a health benefit on the host' It is important to acknowledge that this research field is still in its infancy. Each study reviewed here only explored one probiotic and its effect on one pathogen; as CRS is a complex disease involving whole microbiome dysbiosis, more comprehensive studies looking at multiple probiotic/commensal species interactions are certainly called for. However, the results of these studies at least show enough promise to warrant future research in this area.
Conclusion
Overall, it is clear that the etiology of CRS is not as simple as infection by pathogenic bacteria. Rather, bacteria play a role in the Hot Topic development of CRS through the dysbiosis of the sinus microbiome.
Compared to a healthy sinus microbiome, a CRS microbiome has a decrease in bacterial diversity and evenness, with a loss of some commensal species and overabundance of some pathogenic species. With the emergence of antibiotic resistant bacteria, researchers are starting to explore other treatment options, such as probiotics.
These treatments aim to restore the sinus microbiome to normal, which may contribute to improving the symptoms of CRS.
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